Preventive Antidiarrheal Effective in Subset of Breast Cancer Patients Treated …

Preventive Antidiarrheal Effective in Subset of Breast Cancer Patients Treated …

Phase II open-label study to characterize incidence and severity of diarrhea in patients with early-stage HER2-positive breast cancer treated with neratinib and intensive loperamide prophylaxis [webcast]. Puma Biotechnology Update Call; December 21, …

(Visited 1 times, 1 visits today)
7
Like
Save

Comments

Comments are disabled for this post.